OBN HQ have moved!

Our new address is:

OBN UK Ltd, 5F Park Square, Milton Park, Abingdon OX14 4RR


OBN is the not-for-profit Membership organisation supporting and bringing together the UK’s innovative life sciences companies, corporate partners and investors. Our 400-plus Member companies are located across the Golden Triangle and beyond to Manchester, Nottingham, the Midlands, South Coast and Scotland,  benefiting from our networking, partnering, purchasing, training, advising and advocacy activities.

Become a Member

Click here to see how OBN Membership will benefit your company.

Members Area

Go straight to the latest news, events, conference discounts and opportunities for our Members.

Life Sciences Professionals

How does OBN support individuals? Click for Training and Jobs

OBN Patrons


OBN Sponsors


Karus Therapeutics Announces First Cancer Patients Dosed with KA2507, a Small Molecule HDAC6-Selective Inhibitor, in a Phase I Clinical Trial

Friday, September 22, 2017

This is the Company’s second orally-active small molecule cancer therapeutic agent to enter clinical trials during the past 12 months.

Read more

The CLASP Healthcare call has £2m to fund a small number of projects ranging from short feasibility studies to larger developmental projects

Friday, September 22, 2017

The proposals led by eligible STFC scientists will provide solutions to address the healthcare grand challenges using STFC science, technologies and skills. User engagement is encouraged.

Read more

Replimune Appoints Howard L. Kaufman, M.D., FACS as Chief Medical Officer

Tuesday, September 19, 2017

Replimune Group Inc. announced today a key addition to its senior leadership team as it progresses its Immulytic™ oncolytic immunotherapy platform rapidly towards clinical trials.

Read more

Replimune Raises $55 Million To Advance Its Oncolytic Immunotherapy Programs

Tuesday, September 19, 2017

Biotechnology company focused on developing next generation oncolytic immunotherapies, announced today the completion of a $55 million Series B financing.

Read more

Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases

Monday, September 18, 2017

$40 million investment to accelerate development of Immunocore’s ImmTAV® and ImmTAB® therapeutics for infectious diseases, in particular tuberculosis and HIV

Read more
Read More News


Sterilisation Technical Seminar (STERIS)
Event Start Date: Tue, 26 Sep 2017 00:00:00 GMT
Event End Date: Tue, 26 Sep 2017 23:59:00 GMT
Event Locations

View More Details

OBN Annual Senior Executive Dinner (Invitation-only)
Event Start Date: Tuesday, September 26, 2017 12:00 AM
Event End Date: Tuesday, September 26, 2017 11:59 PM
Event Locations

View More Details

From in vivo studies to human trials the critical gap in between: Immunogenicity and new models in drug research
Event Start Date: Tuesday, September 26, 2017 12:00 PM
Event End Date: Tuesday, September 26, 2017 5:00 PM
Event Locations
Alderley Edge

View More Details

OBN Awards 2017
Event Start Date: Thursday, October 05, 2017 12:00 AM
Event End Date: Thursday, October 05, 2017 11:59 PM
Event Locations

View More Details

OBN Special Collaboration Event with VA Beach Bio ‘How to build your business in the US’
Event Start Date: Thursday, October 05, 2017 2:00 PM
Event End Date: Thursday, October 05, 2017 4:00 PM
Event Locations

View More Details

Read More Events


BRC Partnership and Commercialisation Manager: University of Bristol

We are seeking an enthusiastic and experienced individual to work across the partner institutions to help shape and lead on the implementation of BRC’s industrial engagement strategy

Read more

Research Commercialisation Manager: University of Bristol

We are looking for an enthusiastic and experienced  individual to manage a commercialisation  portfolio with a focus on lifesciences.

Read more

Protein Purification Manager

Protein Purification Manager - West Midlands Permanent position - Competitive salary and benefits package

Read more

Project Manager - Clinical Innovation Adoption and Industry Partnerships

The Oxford Academic Health Science Network (AHSN) is delivering seven programmes and themes that encompass a broad range of initiatives to improve the health outcomes and prosperity of the 3.3m people...

Read more

Chronos Research Technician

Research Technician required for Drug Discovery screening in expanding Oxford Biotech business

Read more
Read More Jobs

OBN Supporters

Investor Supporters

Silicon Valley Bank
SR one
SV Life Sciences




Collaborators and Accreditations

BioHub Birmingham


Department for International Trade